Bulletin of the National Research Centre

Table 11 Statistical analysis of the descriptor used in the QSAR model

From: QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds

	AATS6i	ATSC8i	GATS5s	VR1_Dze	C2SP3	VIF	P value
AATS6i	1					2.077006	0.006999
ATSC8i	0.374295	1				1.272532	0.000162
GATS5s	−0.65093	−0.3855	1			1.984035	3.01E−05
VR1_Dze	0.000492	−0.16932	0.0273	1		1.059332	0.000661
C2SP3	0.280075	0.185489	0.013492	−0.15324	1	1.226411	−4.6729

Back to article page